TBPH
NASDAQStockTheravance Biopharma, Inc.
$13.64-0.24 (-1.76%)
52-Week Range
$8.32
$20.74
Key Stats
Market Cap
691.4M
P/E Ratio
—
Dividend Yield
—
Beta
0.11
Volume
378.4K
Avg Volume
1.1M
Performance
1M
-28.40%
3M
-21.83%
6M
-3.54%
YTD
-23.47%
1Y
+50.49%
3Y
+31.53%
5Y
-32.57%
Price Chart
ETF Exposure
TBPH is held by 102 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| VIRS | Pacer BioThreat Strategy ETF | 0.02% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.02% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| IWN | iShares Russell 2000 Value ETF | 0.01% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| WSML.L | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| USFM.L | UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
About TBPH ETF Exposure
Theravance Biopharma, Inc. (TBPH) is held by 102 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 691.4M, TBPH is a widely held institutional stock. The stock currently trades at $13.64. Investors can gain exposure to TBPH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TBPH, sorted by portfolio weight.